Mark Jeffrey De Long Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

APLS Quotes by TradingView

Mark Jeffrey De Long is Chief Business & Strat Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 78,353 shares of APLS, which is worth approximately $1.59 Million. The most recent transaction as insider was on Jun 15, 2021, when has been sold 4,000 shares (Common Stock) at a price of $15.52 per share, resulting in proceeds of $62,080. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.4K
6.66% 3M change
7.46% 12M change
Total Value Held $1.59 Million

Mark Jeffrey DeLong Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2021
BUY
Exercise of conversion of derivative security
$62,080 $15.52 p/Share
4,000 Added 22.87%
13,490 Common Stock
May 18 2021
SELL
Open market or private sale
$110,000 $55.0 p/Share
2,000 Reduced 17.41%
9,490 Common Stock
May 18 2021
BUY
Exercise of conversion of derivative security
$31,040 $15.52 p/Share
2,000 Added 14.83%
11,490 Common Stock
MJD

Mark Jeffrey De Long

Chief Business & Strat Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APLS